Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure.
Arnold
Donald H
DH
Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
D000293:Adolescent; D019969:Amphetamine-Related Disorders / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy; D002648:Child; D003915:Dextromethorphan / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004347:Drug Interactions; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use*; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D012640:Seizures / Q000139:chemically induced*; D018490:Serotonin Agents / Q000009:adverse effects*; D020230:Serotonin Syndrome / Q000175:diagnosis* / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use*
D000928:Antidepressive Agents; D000996:Antitussive Agents; D003915:Dextromethorphan; D016666:Fluvoxamine; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D018490:Serotonin Agents; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline